Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction of Obetohep 5mg Tablet:
Obetohep 5mg Tablet is used alone or in combination therapy to treat primary biliary cirrhosis. It helps improve liver function by inhibiting the production of bile acid and increasing the removal of bile acid from the liver. This reduces the bile acid in the liver and hence prevents its toxic effects.
Uses of Obetohep 5mg Tablet:
Treatment of Primary biliary cirrhosis
Benefits of Obetohep 5mg Tablet:
In Treatment of Primary biliary cirrhosis:
Primary biliary cholangitis is a type of liver disease that gradually worsens over time. It may not always present symptoms but can eventually lead to liver failure. Obetohep 5mg Tablet is used to treat this condition and may be used alone or with other medicines. It can help prevent or delay liver damage in most people, especially if started early. Once treatment begins, it is likely to continue for life. To enhance the effectiveness of the medicine and for general health benefits, quitting smoking, maintaining a healthy weight, and avoiding excessive alcohol consumption are recommended.
Mechanism of action of Obetohep 5mg Tablet:
Obetohep 5mg Tablet stimulates Farnesoid X receptor (FXR), a chemical that regulates the synthesis and transport of bile acid, lipid metabolism, and regulation of glucose levels. It inhibits bile acid synthesis and increases bile acid secretion. This reduces the bile acid pool in the liver and hence prevents its toxic effects, thereby improving liver function.